Who
Melody B. Meyer
Director
Company insider
Files Form 4 as: Director, AbbVie; Director, Nov.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 5 May 2017
- Last trade
- 8 May 2026
- Last filed
- 12 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,203 at $0.00 | filing |
| 3 May 2024filed 7 May 2024 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,322 at $0.00 | filing |
| 5 May 2023filed 9 May 2023 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,450 at $0.00 | filing |
| 24 May 2022filed 26 May 2022 | NOV NovOilfield services | SEC FORM 4 Code A | —8,473 at $0.00 | filing |
| 6 May 2022filed 9 May 2022 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,421 at $0.00 | filing |
| 19 May 2021filed 20 May 2021 | NOV NovOilfield services | SEC FORM 4 Code A | —9,819 at $0.00 | filing |
| 7 May 2021filed 11 May 2021 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,681 at $0.00 | filing |
| 20 May 2020filed 21 May 2020 | NOV NovOilfield services | SEC FORM 4 Code A | —12,462 at $0.00 | filing |
| 8 May 2020filed 12 May 2020 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —2,333 at $0.00 | filing |
| 28 May 2019filed 29 May 2019 | NOV NovOilfield services | SEC FORM 4 Code A | —8,219 at $0.00 | filing |
| 3 May 2019filed 7 May 2019 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —2,419 at $0.00 | filing |
| 11 May 2018filed 14 May 2018 | NOV NovOilfield services | SEC FORM 4 Code A | —4,429 at $0.00 | filing |
| 4 May 2018filed 7 May 2018 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,899 at $0.00 | filing |
| 5 May 2017filed 9 May 2017 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —2,770 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.